![Phil Tennant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 794 403 $ al 30/06/2026
Phil Tennant is currently the Director at Illinois Biotechnology Innovation Organization.
Since 2024, Mr. Tennant has also been the Chief Commercial Officer at Precigen, Inc. Mr. Tennant completed undergraduate education at the University of Warwick.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PRECIGEN INC 0,05 % | 28/05/2026 | 139.369 ( 0,05 % ) | 794 403 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 23/07/2024 |
Illinois Biotechnology Innovation Organization | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Illinois Biotechnology Innovation Organization |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
